Vision of the proposed research for developing a self-powered, millifluidic lab-on-a-chip device to determine blood conductivity. Credit: Advanced Materials (2024). DOI: 10.1002/adma.202403568 Metabolic disorders, like diabetes and osteoporosis, are burgeoning throughout the world, especially in developing countries. The diagnosis for these disorders is typically a blood test, but because the existing health care infrastructure in remote areas is unable to support these tests, most individuals go undiagnosed and without treatment. Conventional methods also involve labor-intensive and invasive processes which tend to be time-consuming and make real-time monitoring unfeasible, particularly in Read More